The global lenalidomide drug market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market is the increasing prevalence of myeloma cancer. According to American Cancer’s Society, in 2021, around 34,920 cases have been diagnosed with multiple myeloma, which is leading to increasing demand for lenalidomide drugs.

Free Sample Copy @ https://www.omrglobal.com/request-sample/lenalidomide-drug-market

This drug is used for the treatment of multiple myeloma, it is equivalent to thalidomide, however, have fewer side effects such as constipation, sedation, and neuropathy as compared to thalidomide. This drug is used to treat anaemia in patients who are suffering from some kind of myeloma. This drug is also used to treat another disease referred to as mantle cell lymphoma. Even though the treatment for myeloma cancer has advanced rapidly over the years, this disease is still incurable. Myeloma cancer starts in the bone marrow, where the disease causes the antibody-producing cells to transform into cancerous myeloma cells, due to which the formation of abnormal antibodies takes place in the body. The lenalidomide is used in another treatment apart from multiple myeloma, such as myelodysplastic syndrome, and others.

A Full Report of Global Lenalidomide Drug Market is Available at:
https://www.omrglobal.com/industry-reports/lenalidomide-drug-market

Lenalidomide is primarily used for the management of the myelodysplastic syndrome. In September 2021, Dr Reddy’s Laboratories launched the generic version of Lenalidomide known as Reddy- Lenalidomide in Canada. This drug will be used to treat patients who are diagnosed with transfusion-dependent anaemia due to the risk of myelodysplastic syndrome. There have been numerous drugs developed in recent years to treat multiple myeloma, due to which the total survival rate of patients suffering from multiple myeloma has increased as compared to previous years, while toxicity is one of the side effects which is restraining the growth of the lenalidomide market.

Global Lenalidomide Drug Market – Segmentation
By Type
5 mg capsule
10 mg capsule
15 mg capsule
25 mg capsule
By Application
Multiple Myeloma
Myelodysplastic syndrome
Others

Global Lenalidomide Drug Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Celgene
SL Pharma

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/lenalidomide-drug-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404